RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate

Stopped early · Phase 4

Conditions studied: Multiple Sclerosis

In brief

This is a Phase IV, prospective, open-label, multi-center trial to assess the treatment satisfaction in patients with relapsing forms of Multiple Sclerosis (MS) who are currently being treated with, but are considering discontinuing treatment with Tecfidera™.

Key facts

Study ID

NCT02117050

Run by

EMD Serono

People needed

1

Starts

2014-06-01

Expected to finish

2015-04-01

Last updated by the study team

2017-01-23

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Call EMD Serono Medical Information for information on recruiting sites — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.